- What we do
-
-
Routes of delivery
- Oral
- Nasal
- Nose to Brain
- Pulmonary
- Parenteral
-
Development stage
- Pre-clinical
- Phase I to Phase II
- Phase III - Commercial
Our Approach
- Selecting Your CDMO Partner
- Project Management
-
- About us
-
-
A CDMO like no other
- About Us
- Our Facilities
- Our History
- Awards and Achievements
-
Leadership Expertise
- Executive Leadership Team
- Board of Directors
- Careers
-
-
- Resources
- Events
- Contact
Speakers:

Dr. Richard Johnson
Chief Scientific Officer
Dr Richard Johnson is the Founding Director and Chief Scientific Officer at Upperton Pharma Solutions, a UK-based Contract, Development and Manufacturing Organisation (CDMO) and graduated from Warwick University with a PhD Biochemistry. In 1994 he was part of a management buy-out team that founded Andaris Ltd, a research and development company exploiting the use of spray drying technology in the fields of diagnostic imaging and drug delivery. In 1999, Dr Johnson founded Upperton and has overseen significant growth and expansion over the past 25 years, specialising in spray drying and nasal drug development.

Shailesh Mistry
Development Manager
Shailesh is an experienced pharmaceutical scientist specialising in drug formulation and delivery systems focusing on orally inhaled and nasal drug products (OINDPs), spray drying, amorphous solid dispersions, and particle engineering. His expertise spans analytical chemistry, device technologies, and packaging solutions.
With over two decades in the industry, Shailesh has held senior roles at a variety of pharmaceutical companies building a strong foundation in analytical and inhalation sciences. Shailesh holds a BSc (Hons) in Medical Science from the University of Birmingham and is recognised for his technical leadership and problem-solving in pharmaceutical formulation.
Let’s continue the conversation.
Set up a technical call with our experts below to learn more.